These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Old Antiprotozoal Drugs: Are They Still Viable Options for Parasitic Infections or New Options for Other Diseases? Cortez-Maya S; Moreno-Herrera A; Palos I; Rivera G Curr Med Chem; 2020; 27(32):5403-5428. PubMed ID: 31264538 [TBL] [Abstract][Full Text] [Related]
5. Recent Advances in the Discovery of Novel Antiprotozoal Agents. Lee SM; Kim MS; Hayat F; Shin D Molecules; 2019 Oct; 24(21):. PubMed ID: 31661934 [TBL] [Abstract][Full Text] [Related]
7. [New drugs for the treatment of human parasitic protozoa]. Dupouy-Camet J Parassitologia; 2004 Jun; 46(1-2):81-4. PubMed ID: 15305692 [TBL] [Abstract][Full Text] [Related]
8. Repurposing bioenergetic modulators against protozoan parasites responsible for tropical diseases. Martínez-Flórez A; Galizzi M; Izquierdo L; Bustamante JM; Rodriguez A; Rodriguez F; Rodríguez-Cortés A; Alberola J Int J Parasitol Drugs Drug Resist; 2020 Dec; 14():17-27. PubMed ID: 32829099 [TBL] [Abstract][Full Text] [Related]
9. Lysine Deacetylase Inhibitors in Parasites: Past, Present, and Future Perspectives. Hailu GS; Robaa D; Forgione M; Sippl W; Rotili D; Mai A J Med Chem; 2017 Jun; 60(12):4780-4804. PubMed ID: 28241112 [TBL] [Abstract][Full Text] [Related]
10. Computer-Aided Drug Discovery Approaches against the Tropical Infectious Diseases Malaria, Tuberculosis, Trypanosomiasis, and Leishmaniasis. Njogu PM; Guantai EM; Pavadai E; Chibale K ACS Infect Dis; 2016 Jan; 2(1):8-31. PubMed ID: 27622945 [TBL] [Abstract][Full Text] [Related]
11. Chemogenomics and parasitology: small molecules and cell-based assays to study infectious processes. Muskavitch MA; Barteneva N; Gubbels MJ Comb Chem High Throughput Screen; 2008 Sep; 11(8):624-46. PubMed ID: 18795882 [TBL] [Abstract][Full Text] [Related]
12. Dual Inhibition of Parasitic Targets: A Valuable Strategy to Treat Malaria and Neglected Tropical Diseases. Previti S; Di Chio C; Ettari R; Zappalà M Curr Med Chem; 2022; 29(17):2952-2978. PubMed ID: 34375176 [TBL] [Abstract][Full Text] [Related]
13. Ruthenium Metallotherapeutics: Novel Approaches to Combatting Parasitic Infections. Britten NS; Butler JA Curr Med Chem; 2022 Aug; 29(31):5159-5178. PubMed ID: 35366762 [TBL] [Abstract][Full Text] [Related]
14. 2-Amino-1,3,4-thiadiazoles as prospective agents in trypanosomiasis and other parasitoses. Serban G Acta Pharm; 2020 Sep; 70(3):259-290. PubMed ID: 32074064 [TBL] [Abstract][Full Text] [Related]
15. Metal-based drugs for malaria, trypanosomiasis and leishmaniasis: recent achievements and perspectives. Navarro M; Gabbiani C; Messori L; Gambino D Drug Discov Today; 2010 Dec; 15(23-24):1070-8. PubMed ID: 20974285 [TBL] [Abstract][Full Text] [Related]
16. Current developments in the therapy of protozoan infections. Zucca M; Savoia D Open Med Chem J; 2011; 5():4-10. PubMed ID: 21629507 [TBL] [Abstract][Full Text] [Related]
17. Antiparasitic chemotherapy: tinkering with the purine salvage pathway. Datta AK; Datta R; Sen B Adv Exp Med Biol; 2008; 625():116-32. PubMed ID: 18365663 [TBL] [Abstract][Full Text] [Related]
18. Metal complexes as chemotherapeutic agents against tropical diseases: trypanosomiasis, malaria and leishmaniasis. Sánchez-Delgado RA; Anzellotti A Mini Rev Med Chem; 2004 Jan; 4(1):23-30. PubMed ID: 14754440 [TBL] [Abstract][Full Text] [Related]